Patent Assignment
Reel/Frame 024990/0430
Change of Name
Recorded: 2010-09-15
Received: 2010-09-15
Pages: 12
Assignor
NEUROMED PHARMACEUTICALS LTD.
Executed: 2010-09-08
Assignee
ZALICUS PHARMACEUTICALS LTD.
SUITE 301-2389 HEALTH SCIENCES MALL, VANCOUVER, BC, CAX, V6T 1Z3, CANADA
Covered Properties
(40)
Diaryl Piperidine Compounds as Calcium Channel Blockers
Application:
12/441,364 →
Cyclopropyl-Piperazine Compounds as Calcium Channel Blockers
Application:
12/445,256 →
Isoxazole Derivatives as Calcium Channel Blockers
Application:
12/297,596 →
Heterocyclic Compounds as Calcium Channel Blockers
Application:
12/301,673 →
Cyclylamine Derivatives as Calcium Channel Blockers
Application:
12/431,077 →
Diaryl-Cyclylalkyl Derivatives as Calcium Channel Blockers
Application:
12/430,974 →
Di-T-Butylphenyl Piperazines as Calcium Channel Blockers
Application:
12/431,083 →
4-(Aminomethyl)Cyclohexanamine Derivatives as Calcium Channel Blockers
Application:
12/420,785 →
N-Piperidinyl Acetamide Derivatives as Calcium Channel Blockers
Application:
12/420,793 →
Heterocyclic Amide Derivatives as Calcium Channel Blockers
Application:
12/097,035 →
Combination Therapy for Relief of Pain
Application:
11/910,909 →
Amino acid derivatives as calcium channel blockers
Application:
12/152,488 →
Bicyclic Pyrimidine Derivatives as Calcium Channel Blockers
Application:
12/118,492 →
Urea Derivatives as Calcium Channel Blockers
Application:
12/116,920 →
Urea Derivatives as Calcium Channel Blockers
Application:
12/111,131 →
Amide Derivatives as Calcium Channel Blockers
Application:
12/042,277 →
Identities Correlation Infrastructure for Passive Network Monitoring
Application:
11/854,392 →
Novel Rat Calcium Channel Subunits and Related Probes, Cell Lines and Methods
Application:
11/650,813 →
Nucleic Acids Encoding Mammalian T-Type Calcium Channels
Application:
11/649,451 →
Nucleic Acids Encoding Mammalian T-Type Calcium Channels
Application:
11/649,452 →
Calcium Channel Blockers
Application:
11/601,005 →
Diamine Calcium Channel Blockers
Application:
11/351,224 →
Urea Derivatives as Calcium Channel Blockers
Application:
11/215,064 →
Calcium channel blockers comprising two benzhydril moieties
Application:
11/214,218 →
Diarylamine Derivatives as Calcium Channel Blockers
Application:
10/928,564 →
Novel Rat Calcium Channel Subunits and Related Probes, Cell Lines and Methods
Application:
10/924,081 →
Nucleic Acids Encoding ALPHA2 Delta Calcium Channel Subunits and Methods for Making and Using Them
Application:
10/918,602 →
N-Type Calcium Channel Blockers
Application:
10/856,921 →
Calcium channel inhibitors comprising benzhydril spaced from piperazine
Application:
10/821,389 →
Calcium Channel Blockers Comprising Two Benzhydril Moieties
Application:
10/821,584 →
N-Type Calcium Channel Blockers
Application:
10/763,974 →
Fluorescence Based T-Type Channel Assay
Application:
10/754,085 →
Calcium Channel Blockers Comprising Two Benzhydril Moieties
Application:
10/746,932 →
Preferentially Substituted Calcium Channel Blockers
Application:
10/746,933 →
Preferentially Substituted Calcium Channel Blockers
Application:
10/655,393 →
Calcium Channel Blockers Comprising Two Benzhydril Moieties
Application:
10/409,763 →
Calcium Channel Inhibitors Comprising Benzhydril Spaced from Piperazine
Application:
10/409,868 →
Heterocyclic calcium in channel blockers
Application:
10/377,090 →
Preferentially Substituted Calcium Channel Blockers
Application:
10/060,900 →
Partially Saturated Calcium Channel Blockers
Application:
09/818,063 →